期刊文献+

首发精神分裂症患者精神药物使用调查 被引量:1

Survey on Psychotropic Drug Used in First-episode Schizophrenics
下载PDF
导出
摘要 目的 了解首发精神分裂症患者精神药物使用情况。方法 采用回顾性调查研究方法对我院 2 0 0 1年 1~ 6月住院的 2 0 6例首发精神分裂症患者精神药物使用情况进行调查。结果 单一用药到出院者 1 1 4例 ,因用药后疗效不好致换药者2 4例 ,合并用药者 6 8例 ;单一用药频度排列前 4位的是氯氮平、氯丙嗪、舒比利、维思通 ;联用抗胆碱药物者 6 3例。结论 非典型抗精神病药物氯氮平仍是一线抗精神病药物 ,我院对首发精神分裂症患者精神药物使用基本合理 ,但应减少联合用药。 Objective The purpose of the research was to learn the situation of using psychotropic drug in first-episode schizophrenics in our hospital.Methode With retrospective investigation,we survey the situation of using psychotropic drug of 206 first-episode schizophrenics in our hospital from january to june in 2000.Result 114 inpatients used a kind of antipsychotic agent.24 inpatients used other medicine because of unpromising effect.68 inpatients combined two or more antipsychotic agent.The sequence of using a kind of medicine was clozapine,chlorpromazinum,sulpiride,risperidone in turn.63 inpatients used both psychotropic drug and anticholinergic.Conclusion Clozapine,an atypical antipsychotic agent,is still the first to use.The principie of using psyochotropic drug in first-episode schizophrenics in our hospital is right.But we should decrease the chance of using combined medicines.
出处 《健康心理学杂志》 2002年第3期167-168,共2页 Health Psychology Journal
关键词 精神分裂症 精神药物 调查 Schizophrenia Sychotropic drug
  • 相关文献

参考文献8

二级参考文献22

  • 1陆明康,殷美莉,周金娣,彭英芳,郭丽华,刘倩,张良栋.抗精神病药物致粒细胞缺乏症42例分析[J].中华神经科杂志,1994,27(4):252-252. 被引量:13
  • 2夏有春(摘译).出生季节并发症和精神分裂症的关系[J].国外医学:精神病学分册,1998,2:109-109.
  • 3劳振威.有家庭史精神分裂症的出生季节[J].中华神经精神科杂志,1987,20:248-248.
  • 4罗环跃,中华神经精神科杂志,1994年,27卷,9页
  • 5李焕德,国外医学精神病学分册,1993年,20卷,82页
  • 6团体著者,第一届中国-比利时抗精神病药物临床疗效研讨会论文汇编,1989年
  • 7张良栋,中国神经精神疾病杂志,1989年,15卷,306页
  • 8吴天诚,中华神经精神科杂志,1989年,22卷,357页
  • 9蔡能,中华神经精神科杂志,1988年,21卷,311页
  • 10姜佐宁,中华神经精神科杂志,1988年,21卷,267页

共引文献105

同被引文献14

  • 1Chakos M, Lieberman J, Hoffman E, et al. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry, 2001, 158:518-526.
  • 2Kane JM, Marder SR, Schooler NR, et al. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Arch Gen Psychiatry, 2001, 58:965-972.
  • 3Bhana N, Foster RH, Olney R,et al. Olanzapine: an updated review of its use in the management of schizophrenia. Drugs, 2001, 61:111-161.
  • 4Love RC, Nelson MW. Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother, 2000, 1:1441-1453.
  • 5Feltus MS, Gardner DM. Second generation antipsychotics for schizophrenia. Can J Clin Pharmacol, 1999, 6:187-195.
  • 6Conley RR, Love RC, Kelly DL, et al. Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine. Am J Psychiatry, 1999, 156:863-868.
  • 7Meltzer H.Side effects of antipsychotic medications: physician's choice of medication and patient compliance[editorial]. J Clin Psychiatry, 2000, 61 Suppl 8:3-66.
  • 8McCombs JS, Nichol MB, Stimmel GL, et al. Use patterns for antipsychotic medications in medicaid patients with schizophrenia. J Clin Psychiatry, 1999, 60 Suppl 19:5-11.
  • 9Kane JM, Aguglia E, Altamura AC, et al. Guidelines for depot antipsychotic treatment in schizophrenia. Eur Neurop-sychopharmacol, 1998, 8:55 -66.
  • 10Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic:a double-blind comparison with chlorpromazine. Arch Gen Psychiatry, 1988, 45:789-796.

引证文献1

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部